Vaibhav Agrawal MD MBA, MJ, MSHA

Clotting Disorder, Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Assistant Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center

Join to view full profile

1500 E. Duarte RoadDuarte, CA 91010

Dr. Agrawal is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Agrawal's full profile Already have an account?

Summary

Dr. Vaibhav Agrawal, based in Duarte, CA, specializes in Hematology with subspecialties in Hematologic Oncology and Myeloproliferative Disorder Hematology-Oncology. He completed his Hematology Fellowship in 2021 at Stanford Health Care and holds an MD from Chicago Medical School. His employment history includes Research Associate at Helford Clinical Research Hospital and Assistant Clinical Professor at City of Hope, along with fellowships at Stanford University School of Medicine and Indiana University Health University Hospital. His experience covers immunotherapy, hematologic oncology, hematopoietic stem cell transplantation, bone marrow transplantation, and acute myeloid leukemia. Dr. Agrawal has several publications on topics relating to his field.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2021
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2017 - 2020
Geisinger Health SystemResidency, Internal Medicine/Pediatrics, 2013 - 2017
Loyola University Chicago School of LawM.J., Health Care Law, 2011 - 2015
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2013, MD

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2020 - 2028
IL State Medical License 2024 - 2026
IN State Medical License 2018 - 2021
PA State Medical License 2013 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant Start of enrollment: 2024 Jul 12
RECRUITING
PHASE2
Roles: Contact, Principal Investigator
Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory Start of enrollment: 2020 May 04
SUSPENDED
PHASE1
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL Start of enrollment: 2021 Jan 04
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2

Publications & Presentations

PubMed

CAR T‑Cell Therapy as a Bridging Strategy to Second Transplant in Relapsed B‑Cell ALL.
Vaibhav Agrawal, Haoyue Shan, Monzr Al Malki, Amandeep Salhotra, Ahmed Aribi
Transplantation and Cellular Therapy. 2026-10-03
Clinical outcomes of adults with-mutated or rearranged B-cell acute lymphoblastic leukemia.
Rick Y Lin, Jose Tinajero, Zhaohui Gu, Vaibhav Agrawal, Hoda Pourhassan
Leukemia & Lymphoma. 2026-10-01
Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia.
Tamer Othman, Vaibhav Agrawal, Joo Y Song, Zhaohui Gu, Paul Koller
American Journal of Hematology. 2026-10-01

Lectures

A Multi-Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Rela...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018